Latest filing published 21 May 2026 for Cardlytics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -65.8%Entry US$38.30 · Close at T+365 US$13.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John L. Klinck Jr.: trading record in brief
John L. Klinck Jr., listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in State Street Corp, Mellon Financial Corp and Cardlytics, Inc. Over a trading history stretching from 23 January 2006 to 20 May 2026, the count stands at 81 filings.
Market trades split into 1 purchase (€45k) and 27 sales (€7.4M). On balance, insiders were net sellers of €7.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 33 share grants and 16 option exercises.
The newest entry dates from 21 May 2026: an option exercise, in Cardlytics, Inc. The clock since the last published purchase (12 August 2024) now reads 818 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John L. Klinck Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,000 shares0Common StockSEC:0001628280-26-037302:0
- 11,000 shares0Common StockSEC:0001666071-25-000093:0
- 14,000 shares@ US$3.49100.0% of flowCommon StockSEC:0001666071-24-000134:0Canonical exit: 10 Nov 2024 (T+90)
- 28,547 shares0Common StockSEC:0001666071-24-000108:0
- 6,465 sharesCommon StockSEC:0001209191-23-032205:0
- 1,701 shares0Common StockSEC:0001666071-22-000073:0
- 2,023 sharesCommon StockSEC:0001666071-21-000121:0
- 6,000 shares@ US$90.00Common StockSEC:0001666071-20-000282:0
- 6,000 shares@ US$100.00Common StockSEC:0001666071-20-000282:1
- 6,353 sharesCommon StockSEC:0001666071-20-000190:0
- 5,952 shares@ US$84.92Common StockSEC:0001666071-20-000181:0
- 534 shares0Common StockSEC:0001666071-20-000181:1
- 5,952 sharesCommon StockSEC:0001666071-20-000097:0
- 5,801 shares@ US$56.72Common StockSEC:0001666071-19-000171:0
- 360 shares0Common StockSEC:0001666071-19-000171:1
- 359 shares0Common StockSEC:0001666071-19-000171:2
- 8,484 sharesCommon StockSEC:0001209191-19-024018:0
- 13,273 shares0Common StockSEC:0001209191-18-046116:0
- 5,801 sharesCommon StockSEC:0001209191-18-010397:0
- 13,706 shares0Common StockSEC:0000093751-15-000063:0
- 2,614 shares0Common StockSEC:0000093751-15-000063:1
- 23,234 shares0Common StockSEC:0000093751-15-000063:2
- 2,739 shares@ US$76.54Common StockSEC:0000093751-15-000063:3
- 20,856 shares@ US$76.93Common StockSEC:0000093751-15-000025:0
- 25,653 shares@ US$76.50Common StockSEC:0000093751-14-000181:0
25 of 80 declarations
